Molecular Diagnostics Terminates Licenses Granted to MonoGen

Law360, New York (November 20, 2003, 12:00 AM EST) -- Molecular Diagnostics and subsidiares AccuMed International and Oncometrics Imaging terminated their licenses granted to MonoGen for the limited use of certain technologies in the field of cancer detection, Molecular Diagnostics said in a statement.

Molecular Devices said it had terminated the licenses as a result of their invalidity and added that the move would "eliminate the confusion promulgated by MonoGen's claims of rights to the technologies."

The company said the termination of the licensing agreement would allow it to proceed with possible action against other parties...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.